Smith & Nephew plc (SNNUF)
OTCMKTS · Delayed Price · Currency is USD
17.83
+0.12 (0.65%)
Oct 13, 2025, 9:30 AM EDT
Smith & Nephew Market Cap
Smith & Nephew has a market cap or net worth of $14.77 billion as of October 14, 2025. Its market cap has increased by 9.73% in one year.
Market Cap
14.77B
Enterprise Value
17.46B
Revenue
5.94B
Ranking
n/a
PE Ratio
30.08
Stock Price
$17.83
Market Cap Chart
Since December 31, 1985, Smith & Nephew's market cap has increased from 1.18B to 14.77B, an increase of 1,146.73%. That is a compound annual growth rate of 6.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 14.96B | 38.21% |
| Dec 31, 2024 | 10.82B | -9.46% |
| Dec 29, 2023 | 11.95B | 2.84% |
| Dec 30, 2022 | 11.62B | -24.46% |
| Dec 31, 2021 | 15.39B | -14.72% |
| Dec 31, 2020 | 18.04B | -14.87% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 671.65M |
| Glass House Brands | 650.22M |
| Veradigm | 525.44M |
| Northwest Biotherapeutics | 378.75M |
| CytoDyn | 335.98M |
| Nika Pharmaceuticals | 333.67M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 236.17M |